High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients

被引:19
作者
Lu, Xiangxue [1 ]
Zhang, Jialing [1 ]
Wang, Shixiang [1 ]
Yu, Qian [1 ]
Li, Han [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Blood Purificat, Beijing 100020, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
STIMULATING AGENT RESPONSIVENESS; ANEMIA; OUTCOMES; HYPORESPONSIVENESS; INFLAMMATION; ASSOCIATION; CREATININE; MANAGEMENT; MASS; CKD;
D O I
10.1155/2020/1027230
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background. Renal anemia is a common complication of hemodialysis patients. Erythropoietin (EPO) hyporesponsiveness has been recognized as an important factor to poor efficacy of recombinant human erythropoietin in the treatment of renal anemia. More importantly, increased erythropoiesis resistance index (ERI) may be associated with inflammation and increased mortality. Objective. The objective of this research was to investigate correlated factors of EPO responsiveness and to clarify the relationships between EPO hyporesponsiveness and cardiovascular mortality and all-cause mortality among maintenance hemodialysis patients. Methods. This prospective cohort study enrolled 276 maintenance hemodialysis patients for a 55-month follow-up to investigate the factors related to ERI and its relationship to all-cause mortality and cardiovascular mortality. Results. ERI was positively correlated with predialysis serum high-sensitivity C-reactive protein (r=0.234, p<0.001), alkaline phosphatase (r=0.134, p=0.028), and ferritin (r=0.155, p=0.010) and negatively correlated with albumin (r=-0.206, p<0.001) and creatinine (r=-0.232, p<0.001). As multiple linear regression showed, predialysis serum albumin, high-sensitivity C-reactive protein, ferritin, and creatinine were independent correlated factors of ERI (p<0.05). Kaplan-Meier curves showed that the cumulative incidences of both cardiovascular mortality and all-cause mortality were significantly higher in patients with ERI>11.04 IU/kg/w/g/dL (both p<0.01). The high ERI group was significantly associated with higher risk for all-cause mortality (OR 1.781, 95% CI 1.091 to 2.910, p=0.021) and cardiovascular mortality (OR 1.972, 95% CI 1.139 to 3.417, p=0.015) after adjusting for confounders. Conclusions. Predialysis serum albumin, high-sensitivity C-reactive protein, ferritin, and creatinine were independent correlated factors of EPO responsiveness among maintenance hemodialysis patients. Patients with higher ERI values had a higher all-cause mortality rate and cardiovascular mortality rate.
引用
收藏
页数:7
相关论文
共 35 条
[1]  
Antunes Sandra Azevedo, 2016, Braz. J. Nephrol., V38, P70, DOI 10.5935/0101-2800.20160011
[2]   Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations [J].
Bamgbola, Oluwatoyin .
PEDIATRIC NEPHROLOGY, 2012, 27 (02) :195-205
[3]   Hyperparathyroidism and anemia in uremic subjects: A combined therapeutic approach [J].
Brancaccio, D ;
Cozzolino, M ;
Gallieni, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01) :S21-S24
[4]   Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis [J].
Chung, Sungjin ;
Song, Ho Cheol ;
Shin, Seok Joon ;
Ihm, Sang-Hyun ;
Park, Chan Seok ;
Kim, Hee-Yeol ;
Yang, Chul Woo ;
Kim, Yong-Soo ;
Choi, Euy Jin ;
Kim, Yong Kyun .
HEMODIALYSIS INTERNATIONAL, 2012, 16 (02) :181-187
[5]   It's Time to Compare Anemia Management Strategies in Hemodialysis [J].
Coyne, Daniel W. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04) :740-742
[6]   Cardiovascular disease in dialysis patients [J].
Cozzolino, Mario ;
Mangano, Michela ;
Stucchi, Andrea ;
Ciceri, Paola ;
Conte, Ferruccio ;
Galassi, Andrea .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 :28-34
[7]   Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin [J].
Fishbane, S ;
Berns, JS .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1337-1343
[8]   Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018 [J].
Fishbane, Steven ;
Spinowitz, Bruce .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (03) :423-435
[9]   Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan [J].
Fukuma, Shingo ;
Yamaguchi, Takuhiro ;
Hashimoto, Seiji ;
Nakai, Shigeru ;
Iseki, Kunitoshi ;
Tsubakihara, Yoshiharu ;
Fukuhara, Shunichi .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (01) :108-116
[10]   Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure [J].
Gotsman, Israel ;
Shauer, Ayelet ;
Zwas, Donna R. ;
Tahiroglu, Ilgar ;
Lotan, Chaim ;
Keren, Andre .
CLINICAL CARDIOLOGY, 2019, 42 (03) :365-372